Hikma Pharmaceuticals Plc

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00B0LCW083
GBP
15.14
0.07 (0.46%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
Net Sales
2,312.86
2,043.38
1,856.32
1,825.55
1,726.84
1,556.92
1,503.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,312.86
2,043.38
1,856.32
1,825.55
1,726.84
1,556.92
1,503.31
Raw Material Cost
1,238.08
1,091.10
978.69
933.44
869.30
792.71
785.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
490.73
481.42
423.91
436.70
407.61
379.48
376.60
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
69.99
56.83
40.72
42.11
40.76
40.50
45.81
Selling and Distribution Expenses
546.24
424.59
343.20
353.26
345.68
314.23
330.79
Other Expenses
-44.09
-42.13
-36.43
-37.51
-35.27
-33.52
-33.31
Total Expenditure (Excl Depreciation)
1,904.18
1,632.60
1,422.23
1,390.41
1,310.61
1,191.69
1,205.14
Operating Profit (PBDIT) excl Other Income
408.7
410.79999999999995
434.09999999999997
435.09999999999997
416.2
365.20000000000005
298.2
Other Income
-0.80
-7.31
-26.18
-16.38
-2.35
6.75
24.85
Operating Profit (PBDIT)
547.85
557.73
529.34
524.04
467.18
407.23
383.59
Interest
69.99
56.83
40.72
42.11
40.76
40.50
45.81
Exceptional Items
-98.15
-157.50
27.63
58.49
50.17
-65.25
-805.24
Gross Profit (PBDT)
1,074.77
952.28
877.62
892.11
857.54
764.21
718.27
Depreciation
153.65
154.25
121.43
105.28
91.71
81.75
105.60
Profit Before Tax
226.06
189.16
394.82
435.14
384.87
219.74
-573.06
Tax
71.60
34.10
90.16
99.82
3.14
6.00
78.43
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
152.85
152.62
306.11
336.10
380.96
211.49
-654.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
152.85
152.62
306.11
336.10
380.96
211.49
-654.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.61
2.44
-0.73
-0.78
0.78
2.25
3.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
154.46
155.06
305.39
335.32
381.74
213.74
-651.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,724.19
1,774.88
1,811.07
1,561.87
1,598.04
1,323.02
1,119.20
Earnings per share (EPS)
0.69
0.68
1.31
1.41
1.57
0.87
-2.73
Diluted Earnings per share
0.69
0.68
1.31
1.41
1.57
0.87
-2.73
Operating Profit Margin (Excl OI)
17.08%
20.1%
23.38%
23.84%
21.88%
20.47%
16.84%
Gross Profit Margin
16.42%
16.81%
27.81%
29.6%
27.6%
19.36%
-31.1%
PAT Margin
6.61%
7.47%
16.49%
18.41%
22.06%
13.58%
-43.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is 13.19% vs 10.08% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is -0.39% vs -49.21% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is -2.90% vs 1.71% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 23.24% vs 39.56% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has fallen from Dec 2022

Compare Annual Results Of Hikma Pharmaceuticals Plc With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(GBP)
Change(%)
Net Sales
2,312.86
31,376.00
-29,063.14
-92.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,312.86
31,376.00
-29,063.14
-92.63%
Raw Material Cost
1,238.08
9,476.00
-8,237.92
-86.93%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
490.73
8,327.00
-7,836.27
-94.11%
Power Cost
0
0
0.00
Manufacturing Expenses
69.99
644.00
-574.01
-89.13%
Selling and Distribution Expenses
546.24
10,741.00
-10,194.76
-94.91%
Other Expenses
-44.09
-347.40
303.31
87.31%
Total Expenditure (Excl Depreciation)
1,904.18
25,714.00
-23,809.82
-92.59%
Operating Profit (PBDIT) excl Other Income
408.67
5,662.00
-5,253.33
-92.78%
Other Income
-0.80
931.00
-931.80
-100.09%
Operating Profit (PBDIT)
547.85
9,144.00
-8,596.15
-94.01%
Interest
69.99
644.00
-574.01
-89.13%
Exceptional Items
-98.15
-2,469.00
2,370.85
96.02%
Gross Profit (PBDT)
1,074.77
21,900.00
-20,825.23
-95.09%
Depreciation
153.65
2,551.00
-2,397.35
-93.98%
Profit Before Tax
226.06
3,480.00
-3,253.94
-93.50%
Tax
71.60
526.00
-454.40
-86.39%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
152.85
2,575.00
-2,422.15
-94.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
152.85
2,575.00
-2,422.15
-94.06%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
1.61
376.00
-374.39
-99.57%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
154.46
2,951.00
-2,796.54
-94.77%
Equity Capital
0
0
0.00
Face Value
0.00
0.31
0.00
Reserves
1,724.19
13,671.00
-11,946.81
-87.39%
Earnings per share (EPS)
0.69
0.62
0.07
11.29%
Diluted Earnings per share
0.69
0.62
0.07
11.29%
Operating Profit Margin (Excl OI)
17.08%
18.05%
0.00
-0.97%
Gross Profit Margin
16.42%
19.22%
0.00
-2.80%
PAT Margin
6.61%
8.21%
0.00
-1.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 231.29 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 13.19% vs 10.08% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit 15.45 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -0.39% vs -49.21% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 54.86 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -2.90% vs 1.71% in Dec 2022

Annual - Interest
Interest 7.00 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 23.24% vs 39.56% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.08%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has fallen from Dec 2022